Recent advances of PET imaging in clinical radiation oncology
Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …
What does PET imaging bring to neuro-oncology in 2022? a review
JT Zhang-Yin, A Girard, M Bertaux - Cancers, 2022 - mdpi.com
Simple Summary Positron emission tomography (PET) imaging is increasingly used to
supplement MRI in the management of patient with brain tumors. In this article, we provide a …
supplement MRI in the management of patient with brain tumors. In this article, we provide a …
Approaches to PET imaging of glioblastoma
LR Drake, AT Hillmer, Z Cai - Molecules, 2020 - mdpi.com
Glioblastoma multiforme (GBM) is the deadliest type of brain tumor, affecting approximately
three in 100,000 adults annually. Positron emission tomography (PET) imaging provides an …
three in 100,000 adults annually. Positron emission tomography (PET) imaging provides an …
Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas
M Ginet, T Zaragori, PY Marie, V Roch… - European journal of …, 2020 - Springer
Abstract Purpose 18 F-FDopa PET imaging of gliomas is routinely interpreted with
standardized uptake value (SUV)-derived indices. This study aimed to determine the added …
standardized uptake value (SUV)-derived indices. This study aimed to determine the added …
Advanced magnetic resonance imaging in pediatric glioblastomas
FG Gonçalves, AN Viaene, A Vossough - Frontiers in Neurology, 2021 - frontiersin.org
The shortly upcoming 5th edition of the World Health Organization Classification of Tumors
of the Central Nervous System is bringing extensive changes in the terminology of diffuse …
of the Central Nervous System is bringing extensive changes in the terminology of diffuse …
T2 mapping of molecular subtypes of WHO grade II/III gliomas
Background According to the new WHO classification from 2016, molecular profiles have
shown to provide reliable information about prognosis and treatment response. The purpose …
shown to provide reliable information about prognosis and treatment response. The purpose …
Usefulness of 18F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature
F Somme, L Bender, IJ Namer, G Noël, C Bund - Cancer Imaging, 2020 - Springer
Contrast-enhanced magnetic resonance imaging is currently the standard of care in the
management of primary brain tumors, although certain limitations remain. Metabolic imaging …
management of primary brain tumors, although certain limitations remain. Metabolic imaging …
[HTML][HTML] Molecular Imaging Biomarkers for Early Cancer Detection: A Systematic Review of Emerging Technologies and Clinical Applications
Background: Early cancer detection is crucial for improving patient outcomes. Molecular
imaging biomarkers offer the potential for non-invasive, early-stage cancer diagnosis …
imaging biomarkers offer the potential for non-invasive, early-stage cancer diagnosis …
Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival
F John, E Bosnyák, NL Robinette… - Neuro …, 2019 - academic.oup.com
Background Although glioblastomas are heterogeneous brain-infiltrating tumors, their
treatment is mostly focused on the contrast-enhancing tumor mass. In this study, we …
treatment is mostly focused on the contrast-enhancing tumor mass. In this study, we …
[HTML][HTML] Complex Diagnostic Challenges in Glioblastoma: The Role of 18F-FDOPA PET Imaging
Glioblastoma multiforme (GBM) remains one of the most aggressive and lethal forms of brain
cancer, characterized by rapid proliferation and diffuse infiltration into the surrounding brain …
cancer, characterized by rapid proliferation and diffuse infiltration into the surrounding brain …